Company Overview

Company name: Soma Group Holdings
Description: Producer of medical cannabis products in New Zealand. The company offers a range of cannabis products using an innovative science-based cannabinoid R&D (research and development) and production platform.
Year founded:
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Country: New Zealand
Region: Oceania

Financial Highlights

Start up capital raised (USD Million): 0.75
Business status: Profitable
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA): 1.92
Fiscal period: FY 2017
Financing Status: A 10% stake in the company was acquired by Cannex Capital Group for $750000 on November 01, 2018. The company has an innovative science-based cannabinoid R&D and production platform and represents an important first step in Cannex’s international intellectual property development strategy.
Number of active investors:
Profile last updated: 14-Nov-2018
Last known valuation: 7.50
Last known valuation date: 01-Nov-2018